Legal & General Group PLC Seres Therapeutics, Inc. Transaction History

Legal & General Group PLC

$440 Billion
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$0.75 - $1.56 $3,378 - $7,026	-4,504 Reduced 31.09%	9,985 $7,000
Q4 2023 Feb 15, 2024	SELL	$0.93 - $2.15 $66,216 - $153,080	-71,200 Reduced 83.09%	14,489 $20,000
Q3 2023 Nov 14, 2023	SELL	$2.33 - $5.07 $2,232 - $4,857	-958 Reduced 1.11%	85,689 $203,000
Q2 2023 Aug 14, 2023	BUY	$4.67 - $6.55 $207,086 - $290,453	44,344 Added 104.82%	86,647 $415,000
Q1 2023 May 15, 2023	BUY	$4.95 - $6.09 $12,573 - $15,468	2,540 Added 6.39%	42,303 $239,000
Q4 2022 Feb 14, 2023	BUY	$5.09 - $9.05 $2,998 - $5,330	589 Added 1.5%	39,763 $222,000
Q3 2022 Nov 14, 2022	BUY	$3.5 - $7.2 $34,475 - $70,920	9,850 Added 33.59%	39,174 $252,000
Q2 2022 Aug 22, 2022	BUY	$2.7 - $7.62 $753 - $2,125	279 Added 0.96%	29,324 $100,000
Q1 2022 May 16, 2022	SELL	$6.3 - $8.84 $409 - $574	-65 Reduced 0.22%	29,045 $207,000
Q4 2021 Feb 14, 2022	BUY	$6.02 - $11.43 $216 - $411	36 Added 0.12%	29,110 $242,000
Q3 2021 Nov 15, 2021	BUY	$5.46 - $22.6 $73,846 - $305,665	13,525 Added 86.98%	29,074 $202,000
Q2 2021 Aug 12, 2021	BUY	$18.46 - $24.36 $24,348 - $32,130	1,319 Added 9.27%	15,549 $371,000
Q1 2021 May 17, 2021	SELL	$17.66 - $28.92 $8,865 - $14,517	-502 Reduced 3.41%	14,230 $294,000
Q4 2020 Feb 12, 2021	BUY	$23.25 - $37.73 $193,091 - $313,347	8,305 Added 129.22%	14,732 $361,000
Q3 2020 Nov 13, 2020	SELL	$3.74 - $28.74 $3,033 - $23,308	-811 Reduced 11.2%	6,427 $182,000
Q2 2020 Aug 14, 2020	BUY	$3.04 - $6.2 $5,259 - $10,726	1,730 Added 31.41%	7,238 $34,000
Q1 2020 May 14, 2020	SELL	$2.64 - $3.82 $5,470 - $7,915	-2,072 Reduced 27.34%	5,508 $20,000
Q4 2019 Feb 13, 2020	BUY	$2.99 - $4.42 $4,434 - $6,554	1,483 Added 24.32%	7,580 $26,000
Q3 2019 Nov 13, 2019	BUY	$2.29 - $4.16 $6,219 - $11,298	2,716 Added 80.33%	6,097 $24,000
Q1 2018 May 17, 2018	SELL	$7.34 - $11.16 $10,268 - $15,612	-1,399 Reduced 29.27%	3,381 $25,000
Q4 2017 Feb 13, 2018	BUY	$9.15 - $12.64 $43,737 - $60,419	4,780	4,780 $48,000

Others Institutions Holding MCRB

# of Institutions

Shares Held

46.7M

Call Options Held

119K

Put Options Held

466K

Flagship Pioneering Inc. Cambridge, MA

23.1M
Shares

$19 Million
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

6.29M
Shares

$5.15 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.41M
Shares

$1.97 Million
0.21% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1.78M
Shares

$1.46 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.76M
Shares

$1.44 Million
0.0% of portfolio

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $102M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account